Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety (Q47930696)

6 February 2018

title

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety (English)

1 reference

6 February 2018

author name string

Skutella T

1 reference

6 February 2018

Probst JC

1 reference

6 February 2018

Renner U

1 reference

6 February 2018

Holsboer F

1 reference

6 February 2018

Behl C

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

6 February 2018

published in

Neuroscience

1 reference

6 February 2018

volume

1 reference

6 February 2018

issue

1 reference

6 February 2018

page(s)

795-805

1 reference

6 February 2018

Loperamide inhibits corticotrophic cell function by a naloxone-insensitive mechanism in the rat in vitro

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Glucocorticoids Inhibit Corticotropin-Releasing Factor-Induced Production of Adenosine 3′,5′-Monophosphate in Cultured Anterior Pituitary Cells*

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

A sensitive open field measure of anxiolytic drug activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Corticotropin-releasing factor receptors in rat pituitary gland: autoradiographic localization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Synthetic corticotropin-releasing factor stimulates secretion of immunoreactive β-endorphin/β-lipotropin and ACTH by human fetal pituitaries in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

New hypothalamic hormone, corticotropin-releasing factor, specifically stimulates the release of adrenocorticotropic hormone and cortisol in man

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioral effects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

CRF stimulates alpha-MSH secretion and cyclic AMP accumulation in rat pars intermedia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Exposure to an antisense oligonucleotide decreases corticotropin-releasing factor receptor binding in rat pituitary cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Corticotropin-Releasing Factor Stimulates Secretion of Melanocyte-Stimulating Hormone from the Rat Pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

In Vivo Corticotropin-Releasing Factor-Induced Secretion of Adrenocorticotropin, β-Endorphin, and Corticosterone*

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

STUDIES ON SUCCINATE-TETRAZOLIUM REDUCTASE SYSTEMS. III. POINTS OF COUPLING OF FOUR DIFFERENT TETRAZOLIUM SALTS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Primary structure of corticotropin-releasing factor from ovine hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Corticotropin releasing factor produces behavioural activation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Animal models for the study of anti-anxiety agents: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Gene inhibition using antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Antisense oligonucleotide strategies in neuropharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Brain and pituitary receptors for corticotropin releasing factor: Localization and differential regulation after adrenalectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900682-9

7 January 2021

10.1016/S0306-4522(97)00682-9

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018